Back
Speaker illustration

Doctor Kunal Mahajan

Himachal Heart Institute, Himachal Pradesh (India)

Member of:

European Society of Cardiology

Dr. Kunal Mahajan, MD DM FACC FESC FSCAI FAPSC FAPSIC FISH FISC currently works as Chief of Interventional Cardiology in the Himachal Heart Institute, Mandi India. He has a keen interest in Interventional Cardiology as well as preventive cardiology and has more than 100 indexed publications to his credit. He has participated as faculty in various national/international conferences.

Presentations

Impact of elevated lipoprotein(a) on LDL-C lowering efficacy in ACS patients undergoing triple lipid-lowering therapy: insights from LAI-REACT-LP(a) sub-study

Event: ESC Congress 2025

Topic: Lipid-Lowering Agents

Session: Refining efficacy and safety of lipid-lowering pharmacotherapy

Access
Like
Thumbnail

Suboptimal LDL-C control despite high statin use: insights from the LAI-LCARE survey on secondary CAD prevention in India

Event: ESC Congress 2025

Topic: Lipids

Session: Lipids (1)

Access
Like
Thumbnail

Efficacy of combination lipid lowering therapy in achieving low density lipoprotein cholesterol targets after one month of event in patients with acute coronary syndrome

Event: ESC Congress 2024

Topic: Lipid-Lowering Agents

Session: Lipid-lowering therapy: statins and beyond

Access
Like
Thumbnail

Lipid lowering therapy and the unmet targets in Indian patients with angiographically proven coronary artery disease: results from the OLS registry

Event: ESC Congress 2024

Topic: Drug therapy

Session: Lipids as risk factors for cardiovascular disease

Access
Like
Thumbnail

How is juvenile rheumatic heart disease different: baseline results from a prospective north Indian registry

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Valvular Heart Disease ePosters

Access
Like
Thumbnail

How is juvenile rheumatic heart disease different: baseline results from a prospective north Indian registry

Event: ESC Asia with APSC & AFC 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Abstract Programme

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources